Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Marie-Claude L'Heureux & Patricia L Brubaker. (2001) Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2. Annals of Medicine 33:4, pages 229-235.
Read now
Read now
Articles from other publishers (29)
Şule NAMLI KOÇ, Özgül SAĞOL & Mesut AKARSU. (2023) Evaluation of GLP-2 receptor expression in gastrointestinal neuroendocrine tumorsGastrointestinal nöroendokrin tümörlerde GLP-2 reseptör ekspresyonunun değerlendirilmesi. Akademik Gastroenteroloji Dergisi 22:2, pages 52-58.
Crossref
Crossref
Nick Cave, Sean J. Delaney & Jennifer A. Larsen. 2023. Applied Veterinary Clinical Nutrition. Applied Veterinary Clinical Nutrition
235
298
.
Tian Zhang, Lei Shi, Yuan Xu, Yang Li, Shicao Li, Bo Guan, Zhihua Qi, Ye Zhang & Linna Liu. (2019) Purified PEGylated human glucagon-like peptide-2 reduces the severity of irradiation-induced acute radiation enteritis in rats. Journal of Radiation Research 60:1, pages 7-16.
Crossref
Crossref
Patricia L. Brubaker. 2011. Comprehensive Physiology. Comprehensive Physiology
1185
1210
.
Ke-ke Qi, Jie Wu, Jing Wan, Xiao-ming Men & Zi-wei Xu. (2014) Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis. Peptides 52, pages 11-18.
Crossref
Crossref
Kelly A. Tappenden, Jeffrey Edelman & Bo Joelsson. (2013) Teduglutide Enhances Structural Adaptation of the Small Intestinal Mucosa in Patients With Short Bowel Syndrome. Journal of Clinical Gastroenterology 47:7, pages 602-607.
Crossref
Crossref
Nick Cave. 2012. Applied Veterinary Clinical Nutrition. Applied Veterinary Clinical Nutrition
175
219
.
Alan L. Buchman, Seymour Katz, John C. Fang, Charles N. Bernstein & Souheil G. Abou-Assi. (2010) Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease. Inflammatory Bowel Diseases 16:6, pages 962-973.
Crossref
Crossref
Roger Yazbeck, Gordon S. Howarth & Catherine A. Abbott. (2009) Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?. Cytokine & Growth Factor Reviews 20:2, pages 175-184.
Crossref
Crossref
Sandra Torres, Lars Thim, Fabien Milliat, Marie-Catherine Vozenin-Brotons, Ulfe Bang Olsen, Ian Ahnfelt-Rønne, Jean Bourhis, Marc Benderitter & Agnès François. (2007) Glucagon-Like Peptide-2 Improves Both Acute and Late Experimental Radiation Enteritis in the Rat. International Journal of Radiation Oncology*Biology*Physics 69:5, pages 1563-1571.
Crossref
Crossref
David W. Nelson, James W. Sharp, Mark S. Brownfield, Helen E. Raybould & Denise M. Ney. (2007) Localization and Activation of Glucagon-Like Peptide-2 Receptors on Vagal Afferents in the Rat. Endocrinology 148:5, pages 1954-1962.
Crossref
Crossref
K. WALLIS, J. R. F. WALTERS & A. FORBES. (2007) Review article: glucagon-like peptide 2 - current applications and future directions. Alimentary Pharmacology & Therapeutics 25:4, pages 365-372.
Crossref
Crossref
K. Masur, F Schwartz, F. Entschladen, B. Niggemann & K.S. Zaenker. (2006) DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells. Regulatory Peptides 137:3, pages 147-155.
Crossref
Crossref
Jennifer L. EstallDaniel J. Drucker. (2006) Glucagon-Like Peptide-2. Annual Review of Nutrition 26:1, pages 391-411.
Crossref
Crossref
William T. Chance, Sulaiman Sheriff, Ramesh Dayal, Lou Ann Friend, Ingrid Thomas & Ambikaipakan Balasubramaniam. (2006) The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia. Peptides 27:4, pages 883-892.
Crossref
Crossref
Kathleen M. Campbell & William F. Balistreri. 2006. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
1089
1098
.
Eric D Shin, Daniel J Drucker & Patricia L Brubaker. (2005) Glucagon-like peptide 2: an update. Current Opinion in Endocrinology & Diabetes 12:1, pages 63-71.
Crossref
Crossref
C. Booth, D. Booth, S. Williamson, L. L. Demchyshyn & C. S. Potten. (2004) Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage. Cell Proliferation 37:6, pages 385-400.
Crossref
Crossref
Laurie L. Baggio & Daniel J. Drucker. (2004) Glucagon-like peptide-1 and glucagon-like peptide-2. Best Practice & Research Clinical Endocrinology & Metabolism 18:4, pages 531-554.
Crossref
Crossref
Gary R. Martin, Laurie E. Wallace & David L. Sigalet. (2004) Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 286:6, pages G964-G972.
Crossref
Crossref
Kazuto Yamazaki, Nobuyuki Yasuda, Takashi Inoue, Tadashi Nagakura, Kazunobu Kira, Takao Saeki & Isao Tanaka. (2004) The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight. European Journal of Pharmacology 488:1-3, pages 213-218.
Crossref
Crossref
Jennifer L. Estall & Daniel J. Drucker. (2003) Dual Regulation of Cell Proliferation and Survival via Activation of Glucagon-Like Peptide-2 Receptor Signaling. The Journal of Nutrition 133:11, pages 3708-3711.
Crossref
Crossref
Kelly E. Mayo, Laurence J. Miller, Dominique Bataille, Stéphane Dalle, Burkhard Göke, Bernard Thorens & Daniel J. Drucker. (2003) International Union of Pharmacology. XXXV. The Glucagon Receptor Family. Pharmacological Reviews 55:1, pages 167-194.
Crossref
Crossref
D.G. Burrin, B. Stoll & X. Guan. (2003) Glucagon-like peptide 2 function in domestic animals. Domestic Animal Endocrinology 24:2, pages 103-122.
Crossref
Crossref
Daniel J. Drucker. (2003) Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis. Molecular Endocrinology 17:2, pages 161-171.
Crossref
Crossref
Daniel J. Drucker. (2002) Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122:2, pages 531-544.
Crossref
Crossref
Jesper Thulesen, Lotte Bjerre Knudsen, Bolette Hartmann, Sven Hastrup, Hannelouise Kissow, Palle Bekker Jeppesen, Cathrine Ørskov, Jens Juul Holst & Steen Seier Poulsen. (2002) The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist. Regulatory Peptides 103:1, pages 9-15.
Crossref
Crossref
Matthew Bjerknes & Hazel Cheng. (2001) Modulation of specific intestinal epithelial progenitors by enteric neurons. Proceedings of the National Academy of Sciences 98:22, pages 12497-12502.
Crossref
Crossref
William T. Chance, Sulaiman Sheriff, Freda McCarter & Cora Ogle. (2001) Glucagon-Like Peptide-2 Stimulates Gut Mucosal Growth and Immune Response in Burned Rats. Journal of Burn Care & Rehabilitation 22:2, pages 136-143.
Crossref
Crossref